1. Market Research
  2. > Thoratec Corporation (THOR) - Product Pipeline Analysis, 2015 Update

Summary

Thoratec Corporation (Thoratec) is a medical device company. It undertakes the research, development, manufacture and marketing of proprietary medical devices used for mechanical circulatory support for the treatment of heart failure (HF) patients. The major product of the company includes Thoratec Paracorporeal Ventricular Assist DeviceThoratec Implantable Ventricular Assist DeviceHeartMate Left Ventricular Assist Systemand HeartMate II Left Ventricular Assist System. The company also offers acute circulatory support products including CentriMag acute circulatory system and PediMag/PediVAS pediatric acute circulatory system. Thoratec’s products are marketed and sold in the US, Europe, Japan and other countries. The company markets its products to heart transplant hospitals and large cardiac surgery centers. Thoratec is headquartered in California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Thoratec Corporation
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

Thoratec Corporation (THOR) - Product Pipeline Analysis, 2015 Update
Table of Contents


Table of Contents 2

List of Tables
4

List of Figures
5
Thoratec Corporation Company Snapshot 6
Thoratec Corporation Company Overview 6
Key Information 7
Thoratec Corporation Pipeline Products and Clinical Trials Overview 7
Thoratec Corporation - Pipeline Analysis Overview 10
Business Description 10
Key Facts 11
Thoratec Corporation - Major Products and Services 12
Thoratec Corporation Pipeline Products by Development Stage 13
Thoratec Corporation Clinical Trials by Trial Status 15
Thoratec Corporation Pipeline Products Overview 17
Apica VAD SIS Device 17
Apica VAD SIS Device Product Overview 17
Apical Access System 18
Apical Access System Product Overview 18
Automated Anastomosis Device 19
Automated Anastomosis Device Product Overview 19
Fully Implantable Ventricular Assist System 20
Fully Implantable Ventricular Assist System Product Overview 20
HeartMate III LVAS - Bridge-to-Transplant 21
HeartMate III LVAS - Bridge-to-Transplant Product Overview 21
HeartMate III LVAS - Bridge-to-Transplant Clinical Trial 22
HeartMate III LVAS - Destination Therapy 23
HeartMate III LVAS - Destination Therapy Product Overview 23
HeartMate III LVAS - Destination Therapy Clinical Trial 24
HeartMate Percutaneous Heart Pump 25
HeartMate Percutaneous Heart Pump Product Overview 25
HeartMate Percutaneous Heart Pump Clinical Trial 26
HeartMate X 27
HeartMate X Product Overview 27
Next Generation Device For TAVI 28
Next Generation Device For TAVI Product Overview 28
Remote Monitoring Device 29
Remote Monitoring Device Product Overview 29
UltraMag Adult Ventricular Assist System 30
UltraMag Adult Ventricular Assist System Product Overview 30
UltraMag Pediatric Ventricular Assist System 31
UltraMag Pediatric Ventricular Assist System Product Overview 31
Universal Port Access System 32
Universal Port Access System Product Overview 32
Thoratec Corporation - Key Competitors 33
Thoratec Corporation - Key Employees 34
Thoratec Corporation - Key Employee Biographies 35
Thoratec Corporation - Locations And Subsidiaries 36
Head Office 36
Other Locations and Subsidiaries 36
Recent Developments 37
Thoratec Corporation, Recent Developments 37
Feb 10, 2015: Thoratec Reports Fourth Quarter 2014 Results 37
Dec 01, 2014: Thoratec Announces Completion Of Enrollment In The HeartMate III CE Mark Trial 38
Nov 05, 2014: Thoratec Reports Third Quarter 2014 Results 38
Oct 06, 2014: Thoratec Announces Additions To Senior Management Team 39
Sep 22, 2014: Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 39
Sep 09, 2014: Thoratec Announces Start Of Heartmate III U.S. Clinical Trial 40
Aug 06, 2014: Thoratec Reports Second Quarter 2014 Results 41
Aug 06, 2014: Thoratec Announces Start Of The HeartMate PHP CE Mark Trial 42
Jun 27, 2014: Thoratec Announces First HeartMate III Human Implant And Start Of CE Mark Trial 43
May 06, 2014: Thoratec Reports First Quarter 2014 Results 43
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45


List of Tables

Thoratec Corporation, Key Facts 7
Thoratec Corporation Pipeline Products and Clinical Trials Overview 7
Thoratec Corporation Pipeline Products by Equipment Type 8
Thoratec Corporation Pipeline Products by Indication 9
Thoratec Corporation Clinical Trials by Trial Status 9
Thoratec Corporation, Key Facts 11
Thoratec Corporation, Major Products and Services 12
Thoratec Corporation Number of Pipeline Products by Development Stage 13
Thoratec Corporation Pipeline Products Summary by Development Stage 14
Thoratec Corporation Clinical Trials by Trial Status 15
Thoratec Corporation Clinical Trials Summary 16
Apica VAD SIS Device - Product Status 17
Apica VAD SIS Device - Product Description 17
Apical Access System - Product Status 18
Apical Access System - Product Description 18
Automated Anastomosis Device - Product Status 19
Automated Anastomosis Device - Product Description 19
Fully Implantable Ventricular Assist System - Product Status 20
Fully Implantable Ventricular Assist System - Product Description 20
HeartMate III LVAS - Bridge-to-Transplant - Product Status 21
HeartMate III LVAS - Bridge-to-Transplant - Product Description 21
HeartMate III LVAS - Bridge-to-Transplant - Thoratec Corporation HeartMate III IDE Clinical Study Protocol 22
HeartMate III LVAS - Destination Therapy - Product Status 23
HeartMate III LVAS - Destination Therapy - Product Description 23
HeartMate III LVAS - Destination Therapy - Thoratec Corporation Heartmate III CE Mark Clinical Investigation Plan 24
HeartMate Percutaneous Heart Pump - Product Status 25
HeartMate Percutaneous Heart Pump - Product Description 25
HeartMate Percutaneous Heart Pump - HeartMate PHP CE Mark Clinical Investigation Plan 26
HeartMate Percutaneous Heart Pump - Thoratec Corporation HeartMate PHP Cardiogenic Shock Trial 26
HeartMate X - Product Status 27
HeartMate X - Product Description 27
Next Generation Device For TAVI - Product Status 28
Next Generation Device For TAVI - Product Description 28
Remote Monitoring Device - Product Status 29
Remote Monitoring Device - Product Description 29
UltraMag Adult Ventricular Assist System - Product Status 30
UltraMag Adult Ventricular Assist System - Product Description 30
UltraMag Pediatric Ventricular Assist System - Product Status 31
UltraMag Pediatric Ventricular Assist System - Product Description 31
Universal Port Access System - Product Status 32
Universal Port Access System - Product Description 32
Thoratec Corporation, Key Employees 34
Thoratec Corporation, Key Employee Biographies 35
Thoratec Corporation, Subsidiaries 36


List of Figures

Thoratec Corporation Pipeline Products by Equipment Type 8
Thoratec Corporation Pipeline Products by Development Stage 13
Thoratec Corporation Clinical Trials by Trial Status 15

Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.